Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed |
|---|---|---|
|
Adagio Medical Holdings, Inc.
13G/A
ADGM · 00534B100
|
3.2% |
7/28/2026
Event 6/30/2026
|
|
PMV Pharmaceuticals, Inc.
13G/A
PMVP · 69353Y103
|
4.9% |
7/28/2026
Event 6/30/2026
|
|
Serina Therapeutics, Inc.
13G
SER · 81751A108
|
6.7% |
5/4/2026
Event 3/31/2026
|
|
Anteris Technologies Global Corp.
13G/A
AVR · 03675P102
|
5.5% |
5/4/2026
Event 3/31/2026
|
|
Aligos Therapeutics, Inc.
13G/A
ALGS · 01626L204
|
5.5% |
2/11/2026
Event 12/31/2025
|
|
NeuroOne Medical Technologies Corp
13G/A
NMTC · 64130M209
|
4.7% |
11/12/2025
Event 9/30/2025
|
|
Bright Minds Biosciences Inc.
13G/A
DRUG · 10919W405
|
2.7% |
11/12/2025
Event 9/30/2025
|
|
Aprea Therapeutics, Inc.
13G/A
APRE · 03836J201
|
1.9% |
11/12/2025
Event 9/30/2025
|
|
Ventyx Biosciences, Inc.
13G/A
VTYX · 92332V107
|
3.6% |
4/8/2025
Event 3/31/2025
|
|
Vaxart, Inc.
13G
VXRT · 92243A200
|
2.5% |
4/8/2025
Event 3/31/2025
|
|
Q32 Bio Inc.
13G
QTTB · 746964105
|
0% |
4/8/2025
Event 3/31/2025
|
|
Modular Medical, Inc.
13G/A
MODD · 60785L207
|
0.7% |
2/10/2025
Event 12/31/2024
|
|
Aprea Therapeutics, Inc.
13G/A
APRE · 03836J102
|
5.1% |
2/10/2025
Event 12/31/2024
|